Targeting lipid metabolism for the treatment of Anaplastic Thyroid Carcinoma

Por von Roemeling, Christina A., Copland, John A.
Publicado no Expert Opin Ther Targets (2015)

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies

Por Smallridge, Robert C, Marlow, Laura A, Copland, John A
Publicado em 2008

RhoB upregulation leads to either apoptosis or cytostasis through differential target selection

Por Marlow, Laura A., Bok, Ilah, Smallridge, Robert C., Copland, John A.
Publicado no Endocr Relat Cancer (2015)

FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases

Por Storz, Peter, Döppler, Heike, Copland, John A., Simpson, Kaylene J., Toker, Alex
Publicado em 2009

Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer

Por Kourtidis, Antonis, Yanagisawa, Masahiro, Huveldt, Deborah, Copland, John A., Anastasiadis, Panos Z.
Publicado no PLoS One (2015)

Engineering of hetero-functional gold nanorods for the in-vivo molecular targeting of breast cancer cells

Por Eghtedari, Mohammad, Liopo, Anton V., Copland, John A., Oraevsky, Alexander A., Motamedi, Massoud
Publicado em 2009

Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein

Por Kang, Jonghoon, Lee, Myung Soog, Copland, John A., Luxon, Bruce A., Gorenstein, David G.
Publicado em 2008

HYPOXIA NEGATIVELY REGULATES HEPARAN SULFATASE 2 EXPRESSION IN RENAL CANCER CELL LINES

Por Khurana, Ashwani, Tun, Han W, Marlow, Laura, Copland, John A, Dredge, Keith, Shridhar, Viji
Publicado em 2011

Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups

Por Patel, Tejal A., Colon-Otero, Gerardo, Bueno Hume, Celyne, Copland, John A., Perez, Edith A.
Publicado em 2010

p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression

Por Soto, Edwin, Yanagisawa, Masahiro, Marlow, Laura A., Copland, John A., Perez, Edith A., Anastasiadis, Panos Z.
Publicado em 2008

Type III Transforming Growth Factor-β (TGF-β) Receptor Mediates Apoptosis in Renal Cell Carcinoma Independent of the Canonical TGF-β Signaling Pathway

Por Margulis, Vitaly, Maity, Tapati, Zhang, Xiu-Ying, Cooper, Simon J., Copland, John A., Wood, Christopher G.
Publicado em 2008

PRSS3/Mesotrypsin is a therapeutic target for metastatic prostate cancer

Por Hockla, Alexandra, Miller, Erin, Salameh, Moh’d A., Copland, John A., Radisky, Derek C., Radisky, Evette S.
Publicado em 2012

Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma

Por von Roemeling, Christina A, Marlow, Laura A, Kennedy, William P, Kennedy, Gregory T, Copland, John A, Menefee, Michael E
Publicado em 2013

A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease

Por Yanagisawa, Masahiro, Huveldt, Deborah, Kreinest, Pamela, Lohse, Christine M., Cheville, John C., Parker, Alexander S., Copland, John A., Anastasiadis, Panos Z.
Publicado em 2008

Selective central nervous system tropism of primary central nervous system lymphoma

Por Jiang, Liuyan, Marlow, Laura A, Cooper, Simon J, Roemeling, Christina V, Menke, David M, Copland, John A, Tun, Han W
Publicado em 2010

Expression of the type III TGF-β receptor is negatively regulated by TGF-β

Por Hempel, Nadine, How, Tam, Cooper, Simon J., Green, Tyler R., Dong, Mei, Copland, John A., Wood, Christopher G., Blobe, Gerard C.
Publicado em 2008

RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer

Por Vishnu, Prakash, Colon-Otero, Gerardo, Kennedy, Gregory T., Marlow, Laura A., Kennedy, William P., Wu, Kevin J., Santoso, Joseph T., Copland, John A.
Publicado em 2011

A MALDI Imaging Mass Spectrometry Workflow for Spatial Profiling Analysis of N-linked Glycan Expression in Tissues

Por Powers, Thomas W., Jones, E. Ellen, Betesh, Lucy R., Romano, Patrick, Gao, Peng, Copland, John A., Mehta, Anand S., Drake, Richard R.
Publicado em 2013

Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line

Por Mishra, Sweta, Tang, Yuping, Wang, Long, deGraffenried, Linda, Yeh, I-Tien, Werner, Sherry, Troyer, Dean, Copland, John A., Sun, Lu-Zhe
Publicado em 2011

The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro()

Por Becker, Marie N., Wu, Kevin J., Marlow, Laura A., Kreinest, Pamela A., vonRoemeling, Christina A., Copland, John A., Williams, Christopher R.
Publicado no Urol Oncol (2013)